Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

High accurate and precise quantification analysis of GeLC-MS/MS with dimethyl labeling.

ABSTRACT: Dataset of GeLC-MS/MS with light- and heavy-dimethyl labeling of Mouse brain samples.

ORGANISM(S): Mus Musculus (mouse)

SUBMITTER: Yoshio Kodera

PROVIDER: PXD021049 | JPOST Repository | Sat Aug 21 00:00:00 BST 2021

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	Akon122_002_XY1_2_0o021ug_6uL_T40.raw	Raw
	Akon122_003_XY1_3_0o025ug_6uL_T40.raw	Raw
	Akon122_004_XY1_4_0o027ug_6uL_T40.raw	Raw
	Akon122_005_XY1_5_0o022ug_6uL_T40.raw	Raw
	Akon122_007_XZ1_2_0o023ug_6uL_T40.raw	Raw

Items per page:

1 - 5 of 20

Similar Datasets

High accurate and precise quantification analysis of GeLC-MS/MS with dimethyl labeling (label efficiency).

Project description:Dataset of light-dimethyl labeling of Mouse brain samples.

2021-11-18 | PXD022591 | JPOST Repository

Recombinant human serum albumin: limited digestion by chymotrypsin depending on the enzyme concentration

Project description:Dataset of GeLC-MS/MS with light- and heavy- dimethyl labeling of HSA using limited digestion.

2021-12-21 | PXD023253 | JPOST Repository

CIP SILAC GeLC FT MS - Analysis of the membrane proteome of ciprofloxacin-resistant macrophages by stable isotope labeling with amino acids in cell culture (SILAC)

Project description:SILAC-based GeLC FT-ICR MS approach on Light labeled Ciprofloxacin-resistant J774 macrophage membrane proteome and Heavy labeled WT J774 macrophage membrane proteome (Fraction F2).

2013-02-19 | PRD000419 | Pride

Dimethyl labeled murine liver LC-MS data

Project description:Dimethyl-labeled murine liver LC-MS data. We investigated a novel experimental approach to study protein turnover using LC-MS. We duplexed the unlabeled and deuterium-labeled samples through dimethyl labeling, utilizing light and heavy channels.

2025-08-11 | MSV000098797 | MassIVE

Glomus sp. MS strain:MS

Project description:Glomus sp. MS strain:MS Genome sequencing

| PRJNA210520 | ENA

MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS) mRNA

Project description:MicroRNAs are small noncoding RNA molecules that are involved in the control of gene expression. To investigate the role of microRNA in multiple sclerosis (MS), we performed global microarray analyses of mRNA and microRNA in peripheral blood T-cells from relapsing-remitting MS patients and controls. We identified 2,452 regulated genes and 21 regulated microRNA that differed between MS patients and controls. By Kolmogorov-Smirnov test, 20 of 21 regulated microRNA were shown to affect the expression of their target genes, many of which are involved in the immune system. LIGHT (TNFSF14) was a microRNA target gene significantly decreased in MS. The down-regulation of mir-494 and predicted mRNA-target LIGHT was verified by real-time PCR and we could demonstrate decreased serum levels of LIGHT in MS. Thus, regulated microRNA were significantly associated with both gene and protein expression of a molecule in immunological pathways. These findings indicate that microRNA may be important regulatory molecules in T-cells in MS.

2013-08-02 | GSE43591 | GEO

MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS) miRNA

2013-08-02 | GSE43590 | GEO

Circulating microRNAs in relapsing MS patients treated with dimethyl fumarate in the phase 4 TREMEND trial

Project description:Dimethyl fumarate (DMF) is an oral drug approved for relapsing multiple sclerosis (MS) that leads to reduction of neurofilament light (NFL). This may be related to dynamics and persistence of microRNA signatures in the peripheral blood of treatment-naïve MS patients before and after dimethyl fumarate (DMF) at different time points. 210 blood samples were collected from 51 treatment-naïve patients at baseline (BL) and after 1-3, 4-7, 9-15 and 21-27 months of DMF and from 22 controls from the phase IV TREMEND trial. Using microarray, 1,085 miRNAs were two-folds above the background and compared versus NFL. Altered miRNA profiles peaked after 4-7 months. MiR-16-5p and miR-4306, involved in the NF-kB-pathway, were upregulated in low NFL samples, while miR-940 and miR-4665-3p were upregulated in high NFL samples. NFL and miRNA correlations were strongest after 4-7 months DMF. In four patients with blood samples taken at all 5 time points, time-series analysis found miR-146a-5p, the inhibitor of the NF-kB-pathway, increased 1-3 months after treatment. DMF induces dynamic changes in composite miRNA profiles 4-7 months after initiation, several involved in the NF-kB-pathway. Upregulation of miR-16-5p and miR-4306 in low-NFL, while miR-940 and miR-4665-3p in high-NFL samples may indicate a response to DMF treatment.

2022-10-26 | GSE215450 | GEO

Methanosarcina barkeri MS strain:MS

Project description:Methanosarcina barkeri MS strain:MS Raw sequence reads

| PRJNA613292 | ENA

MicroRNA regulate immune pathways in T-cells in multiple sclerosis (MS) miRNA

2013-08-02 | E-GEOD-43590 | biostudies-arrayexpress